# Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses.

> **NCT03902496** · NA · COMPLETED · sponsor: **Avulux, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Migraine

## Interventions

- **OTHER:** HIT-6 Questionnaire
- **DEVICE:** Avulux Spectacles
- **DEVICE:** Sham Spectacles

## Key facts

- **NCT ID:** NCT03902496
- **Lead sponsor:** Avulux, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-18
- **Primary completion:** 2019-05-17
- **Final completion:** 2019-05-17
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03902496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03902496, "Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03902496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*